RET and medullary thyroid gland carcinoma: MEN2B is commonly associated with mutations in the tyrosine kinase domains in exons 15 and 16 (codons 883, 891 and 918), and M918T is recognized as the highest risk mutation for MTC, followed by C634 and A883F.